All News #Library
Biotech
Corcept Presents MOMENTUM Trial Data At ACC Session
28 Mar 2026 //
BUSINESSWIRE
Corcept shares surge as lead drug gets FDA nod for ovarian Cancer
25 Mar 2026 //
PRESS RELEASE
Corcept’s Relacorilant Benefits PARPi-Treated Ovarian Cancer
19 Oct 2025 //
BUSINESSWIRE
Corcept Seeks EMA Approval For Relacorilant
14 Oct 2025 //
BUSINESSWIRE
Corcept to present late-breaking data from Rosella trial at ASCO Meeting
23 Apr 2025 //
BUSINESSWIRE
Corcept Starts Trial in Platinum-Resistant Ovarian Cancer
07 Apr 2025 //
BUSINESSWIRE
Corcept`s Phase 3 trial meets primary endpoint in ovarian cancer
01 Apr 2025 //
BUSINESSWIRE

Market Place
Sourcing Support